Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease:: systematic review

被引:223
作者
Raghunath, A [1 ]
Hungin, APS
Wooff, D
Childs, A
机构
[1] Univ Durham, Ctr Integrated Hlth Care Res, Wolfson Res Inst, Stoke On Tees TS17 6BH, Staffs, England
[2] Univ Durham, Dept Math Sci, Stat & Math Consultancy Unit, Sci Labs, Durham DH1 3LE, England
[3] Northumbria Univ, Informat Management Res Inst, Sch Informat Studies, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England
来源
BMJ-BRITISH MEDICAL JOURNAL | 2003年 / 326卷 / 7392期
关键词
D O I
10.1136/bmj.326.7392.737
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To ascertain the prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease and its association with the disease. Design Systematic review of studies reporting the prevalence of H pylori in patients with and without gastro-oesophageal reflux disease. Data sources Four electronic databases, searched to November 2001, experts, pharmaceutical companies, and journals. Main outcome measure Odds ratio for prevalence of H pylori in patients with gastro-oesophageal reflux disease. Results 20 studies were included. The pooled estimate of the odds ratio for prevalence of H pylori was 0.60 (95% confidence interval 0.47 to 0.78), indicating a lower prevalence in patients with gastro-oesophageal reflux disease. Substantial heterogeneity was observed between studies. Location seemed to be an important factor, with a much lower prevalence of H pylori in patients with gastro-oesophageal reflux disease in studies from the Far East, despite a higher overall prevalence of infection than western Europe and North America. Year of study was not a source of heterogeneity. Conclusion The prevalence of H pylori infection was significantly lower in patients with than without gastro-oesophageal reflux, with geographical location being a strong contributor to the heterogeneity between studies. Patients from die Far East with reflux disease had a lower prevalence of H pylori infection than patients from western Europe and North America, despite a higher prevalence in the general population.
引用
收藏
页码:737 / 739
页数:5
相关论文
共 55 条
[1]   BARRETTS-ESOPHAGUS AND HELICOBACTER-PYLORI [J].
ABBAS, Z ;
HUSSAINY, AS ;
IBRAHIM, F ;
JAFRI, SMW ;
SHAIKH, H ;
KHAN, AH .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1995, 10 (03) :331-333
[2]  
[Anonymous], EUR J GASTROENTEROL
[3]  
BATE CM, 1998, J DRUG ASSESS, V1, P209
[4]   Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole [J].
Berstad, AE ;
Hatlebakk, JG ;
Maartmann-Moe, H ;
Berstad, A ;
Brandtzaeg, P .
GUT, 1997, 41 (06) :740-747
[5]   Statistics notes - The odds ratio [J].
Bland, JM ;
Altman, DG .
BRITISH MEDICAL JOURNAL, 2000, 320 (7247) :1468-1468
[6]  
Boixeda D, 1995, MED CLIN-BARCELONA, V105, P774
[7]   PREVALENCE OF CAMPYLOBACTER-PYLORI IN ESOPHAGITIS, GASTRITIS, AND DUODENAL DISEASE [J].
CHENG, EH ;
BERMANSKI, P ;
SILVERSMITH, M ;
VALENSTEIN, P ;
KAWANISHI, H .
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (06) :1373-1375
[8]  
COOPER BT, 1991, CULLEI, V1, P173
[9]  
Csendes A, 1997, Dis Esophagus, V10, P38
[10]  
DEKOSTER E, GASTROENTEROLOGY S, V108, pA81